home   genetic news   bioinformatics   biotechnology   literature   journals   ethics   positions   events   sitemap
 
  HUM-MOLGEN -> biomedical companies   |   search    |   registration     |   modification  
 

registry of biomedical companies

 
  July 11, 2020
promoting the transfer of scientific know-how between industry and academia
 
 
Registry of biomedical companies:

[3] [4] [A] [B] [C] [D] [E] [F] [G] [H] [I] [J] [K] [L] [M] [N] [O] [P] [Q] [R] [S] [T] [U] [V] [W] [Z] 520 active entries

Medica & Communications7

An SBO Co.
Canada
Canada
Toll free: +011-604-941-9022 (Helpline)

Phone: +011-604-945-8408
Fax: +011-604-941-9022
E-Mail: This e-mail address is being protected from spam bots, you need JavaScript enabled to view it

Description:

Biotechnology and Development journal. (c) 2020. Skye Blue Publications. Port Coquitlam. BC. Canada V3B 1G3.

 

Protein Deficiency and the Chronic Inflammatory Condition: a role for selenoproteins.

 

By   Danny A. Flores1, Skye Blue Publications, Port Coquitlam, B. C. Canada V3B 1G3

 

Correspondence Address:

1 Skye Blue Publications, Port Coquitlam, B. C. V3B 1G3 Canada.

 

I  Introduction.

Animal livestock protein deficiency leads to lower selenoprotein levels and activity from herbage, grains and other cereals and could possibly arise with selenium deficiencies in soil. In human beings on ther other hand protein deficiency leads to a weaker immune system, amongst other disorders.

We will discuss in brief the possible underlying mechanisms at the cellular/molecular level implicating protein status and immunity using selenoprotein status and function as an biomarkered indicator.

 

II  Selenium and Protein Deficiency and Immune Health.

It has been stated by Z. Huang et al. (2012) that selenium immune deficiency relates to activation, differentiation and proliferation in immune cell function, in particular, immune cell signaling regards: (a) redox signaling, (b) oxidative burst, (c) calcium flux and (d) effector functions at the cellular/molecular level.

We are also interested in determining protein deficiency assayed in cell culture in situ from animal models by given indices such as in plasma as in plasma albumin and specific plasma enzyme activities involving selenoproteins (see: Z. Huang et al., 2012).

 

III  Selenium Related to Immune Health.

Selenium has multiple biological activities and depends on the level of selenium intake; the hierarchy of activities calls for selenium biomarker assessment at different levels of selenium exposure such as GPX3 and SEPP1 which can report directly functional activity from assay and identify deficiencies and their relationship to deficient individuals.  The range for selenium assay is <20 ug/kg diet for animals and <55 ug.day for humans in deficient individuals (G. F. Combs, 2015).

Other selenium biomarkers are also needed to assess selenium status in non-deficient individuals such as in cancer risk reduction  is a primary consideration; other biomarkers for which analytical methods are just beginning to be proposed are for the low molecular weight selenium-metabolites, i. e. selenoamino acids and methylated selenium metabolites not detectable to date in biological specimens (G. F. Combs, 2015). 

 

IV Conclusions.

Can we make the bold proposition that selenium proteins are a biomarker for protein status and adds to the growing body of evidence that protein status and immune health including related conditions as in cancer risk levels, i. e. in acquiring the disease state have a cause and effect relationship. Indeed other neurocrine functions on immune health should also be explored in this regard. 

 

References:

1) G. F. Combs, Jr. 2015. Biomarkers of selenium states. Nutrients 7(4): 2209-2236. 

2) Z. Huang, A. H. Rose and P. R. Hoffmann. 2002.  The role of selenium in inflammation and immunity: from molecular mechanisms to therapeutic opportunities.  Antioxid. Redox Signal. 16(7):705-743.

 

//END 



Selected Categories:
Product Company   Service Company
Contract
- Services
Professional
- Communications

Last update of this entry: June 26, 2020

   
 
home   genetic news   bioinformatics   biotechnology   literature   journals   ethics   positions   events   sitemap
 
 
 

Generated by companies 4.0 by Kai Garlipp
WWW: Kai Garlipp, Frank S. Zollmann.
7.0 © 1995-2020 HUM-MOLGEN. All rights reserved. Liability, Copyright and Imprint.